Data
Treatment success as of 2017 in XDR TB
Tuberculosis surveillance and monitoring in Europe 2019-2017
Publication
Tuberculosis surveillance and monitoring in Europe, 2018
The Annual TB Surveillance and Monitoring report presents the key figures and trends and provides an overview of the TB situation in the EU/EEA and the WHO European Region.
Peer-Reviewed Publication
Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania
Popovici, O., Monk, P., Chemtob, D., Chiotan, D., Freidlin, P.J., Groenheit, R., Haanperä, M., Homorodean, D., Mansjö, M., Robinson, E., Rorman, E., Smith, G., Soini, H., Van Der Werf, M.J.
Publication
Communicable disease threats report, 23-29 October 2016, week 43
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 October 2016 and includes updates on Zika virus, Salmonella and extensively drug-resistant TB.
Publication
Communicable disease threats report, 16 - 22 October 2016, week 42
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 October 2016 and includes updates on Zika virus, Salmonella and extensively drug-resistant TB.
Peer-Reviewed Publication
Drug resistance among tuberculosis cases in the European Union and European economic area, 2007 to 2012
Van Der Werf M.J., Ködmön, C., Hollo, V., Sandgren, A., Zucs, P.
Peer-Reviewed Publication
Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011
De Beer, J.L., Ködmön, C., van der Werf, MJ., van Ingen, J., van Soolingen, D., the ECDC MDR-TB molecular surveillance project participants
Peer-Reviewed Publication
Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Lange, C., Abubakar, I., Alffenaar, J.-W.C., Bothamley, G., Caminero, J.A., Carvalho, A.C.C., Chang, K.-C., Codecasa, L., Correia, A., Crudu, V., Davies, P., Dedicoat, M., Drobniewski, F., Duarte, R., Ehlers, C., Erkens, C., Goletti, D., Gunther, G., Ibraim, E., Kampmann, B., Kuksa, L., de Lange, W., van Leth, F., van Lunzen, J., Matteelli, A., Menzies, D., Monedero, I., Richter, E., Rusch-Gerdes, S., Sandgren, A., Scardigli, A., Skrahina, A., Tortoli, E., Volchenkov, G., Wagner, D., Van Der Werf, M.J., Williams, B., Yew, W.-W., Zellweger, J.-P., Cirillo, D.M.
Peer-Reviewed Publication
Supporting TB clinicians managing difficult cases: the ERS/WHO consilium
Blasi, F., Dara, M., van der Werf, M.J., Migliori, G.B.,
Publication
Communicable disease threats report, 18-24 March 2012, week 12
Since November 2011, the so-called Schmallenberg virus (SBV) has been reported in cattle, sheep and goats in Germany, the Netherlands, Belgium, the United Kingdom, France, Luxembourg, Italy and now Spain. The Dutch Central Veterinary Institute found anti-SBV antibodies in 70 percent of samples taken from Dutch cattle between 1 November 2011 and 1 February 2012. This indicates widespread infection and an underestimation of total cases of infection with the virus.